Bruce R. Schackman, Ph.D.
Affiliations: | 2001 | Harvard University, Cambridge, MA, United States |
Area:
Public HealthGoogle:
"Bruce Schackman"Cross-listing: PHTree
Parents
Sign in to add mentorMilton C. Weinstein | grad student | 2001 | Harvard | |
(The cost -effectiveness of early antiretroviral therapy for HIV -infected adults.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Starbird LE, Gutkind S, Teixeira P, et al. (2023) Economic Cost of the HealthCall Smartphone Intervention to Reduce Heavy Alcohol Drinking in Adults with HIV. Journal of Studies On Alcohol and Drugs |
Martel-Laferrière V, Feaster DJ, Metsch LR, et al. (2022) Correction: MHepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID. Trials. 23: 815 |
Gutkind S, Starbird LE, Murphy SM, et al. (2022) Cost of Hepatitis C care facilitation for HIV/Hepatitis C Co-infected people who use drugs. Drug and Alcohol Dependence. 232: 109265 |
Zang X, Mah C, Linh Quan AM, et al. (2021) Human Immunodeficiency Virus transmission by HIV risk group and along the HIV care continuum: A contrast of six US cities. Journal of Acquired Immune Deficiency Syndromes (1999) |
Quan AML, Mah C, Krebs E, et al. (2021) Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities. The Lancet. Hiv |
Behrends CN, Kapadia SN, Schackman BR, et al. (2020) Addressing Barriers to On-site HIV and HCV Testing Services in Methadone Maintenance Treatment Programs in the United States: Findings From a National Multisite Qualitative Study. Journal of Public Health Management and Practice : Jphmp |
Zang X, Krebs E, Chen S, et al. (2020) The potential epidemiological impact of COVID-19 on the HIV/AIDS epidemic and the cost-effectiveness of linked, opt-out HIV testing: A modeling study in six US cities. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
Jordan AE, Cleland CM, Wyka K, et al. (2020) Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City. The Journal of Infectious Diseases. 222: S322-S334 |
Jordan AE, Cleland CM, Schackman BR, et al. (2020) Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program. The Journal of Infectious Diseases. 222: S335-S345 |
Krebs E, Zang X, Enns B, et al. (2020) Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities. The Journal of Infectious Diseases. 222: S301-S311 |